Use of high flow in patients with restrictive respiratory pathologies
Alto flujo y patologías respiratorias
DOI:
https://doi.org/10.62059/LatArXiv.preprints.147Keywords:
Restrictive pathologies, High flow, Oxygen therapyAbstract
Restrictive respiratory pathologies (RRP) such as pulmonary fibrosis, interstitial lung disease, and systemic sclerosis are characterized by a decrease in the lungs' ability to expand and contract adequately. This leads to dyspnea, hypoxemia, and reduced quality of life. In severe cases, mechanical ventilatory support may be required. The main objective of the present study is to evaluate the available evidence on the use of high-flow oxygen (HFO) in patients with RRP. We seek to analyze in detail the physiological effects of HFO in this context, the potential clinical benefits, the safety considerations associated with its use and the areas that require further investigation. The design of the study was descriptive, cross-sectional, retrospective literature review type. HFO has emerged as a promising alternative to conventional mechanical ventilation. Studies show that HFO improves oxygenation, decreases the work of breathing, and increases lung capacity in patients with RRP. Clinically, reduction in dyspnea, less need for intubation and reduction in mortality have been observed. HFO emerges as a promising therapeutic option, with applications in the management of acute decompensations and pulmonary rehabilitation programs. However, more research is needed to define its optimal role in the treatment of restrictive respiratory pathologies.
References
Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020;46(6):1099-102.
Nava S, Schreiber A, Domenighetti G, Gnaegi A. Noninvasive ventilation for patients with acute lung injury or acute respiratory distress syndrome. Respir Care. 2011;56(10):1583-8.
Lamb VL, Acton L, Maitra S, Garner AA, Finfer SR, Bellomo R. High-flow nasal cannula oxygen therapy for chronic respiratory failure in adults. Cochrane Database Syst Rev. 2020;1:CD013382.
Zhang Y, Xiang G, Pan Y, Gu W, Wang Y, Xie J, et al. High-flow nasal cannula oxygen therapy for acute respiratory failure in adults with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respirology. 2021;26(11):1426-35.
Khan M, Hasan O, Akhtar N, Akhtar M, Mian A, Rehman A. Safety of high-flow nasal cannula oxygen therapy in critically ill patients: a systematic review and meta-analysis. Crit Care. 2018;22(1):183.
Gattinoni L, Chiumello D, Rossi S. COVID-19 pneumonia: ARDS or not? Crit Care. 2020;24(1):154.
Stankiewicz MK, Garbicz D, Krenke R, Kujawa M, Baran J, Skoczyński S, et al. High-flow nasal cannula oxygen therapy for idiopathic pulmonary fibrosis: a randomized controlled trial. BMC Pulm Med. 2022;22(1):97.
Wang J, Shen Y, Zhang K, Zhu Y, Xu X, Xu L, et al. Effect of high-flow nasal cannula oxygen therapy on mortality in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials. Medicine (Baltimore). 2021;100(50): e28232.
Pelosi P, Chiumello D, Calderini E. Pulmonary and extrapulmonary acute respiratory distress syndrome are different. Curr Opin Crit Care. 2020;26(1):24-31.
Meyer L, Ebmeier S, Glanville AR, Kermeen F, Levvey B, Modry D, et al. High-flow nasal cannula oxygen therapy in pulmonary rehabilitation: a systematic review of randomized controlled trials. Eur Respir J. 2017;50(6):1600203.
Gattinoni L, Marini JJ, Collino F, Maiolo G, Rapetti F, Tonetti T, et al. The future of mechanical ventilation: lessons from the present and the past. Crit Care. 2017;21(1):183.
Mukherjee D, Mukherjee R. High-Flow Nasal Cannula Oxygen Therapy in the Management of Respiratory Failure: A Review. Cureus. 2023;15(12): e50738.
Radtke T, Böni L, Benden C, Maggi-Beba M, Sievi NA, Kohler M, et al. Impact of high-flow oxygen therapy during exercise in idiopathic pulmonary fibrosis: a pilot crossover clinical trial. BMC Pulm Med. 2021;21(1):355. doi: 10.1186/s12890-021-01727-9.
Gao Z, Jiang Y, Yin Y, Xu Y, Gao Z, Xu X, et al. High-flow nasal cannula oxygen therapy versus conventional oxygen therapy in patients with acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res. 2023;24(1):33. doi: 10.1186/s12931-023-02334-1.
Yamaguchi T, Kanezaki M, Matsumoto T, Kubo H, Nishiyama O, Senjyu H. Effects of high-flow nasal cannula oxygen therapy on exercise capacity in patients with interstitial lung disease. Respir Investig. 2021;59(2):202-209. doi: 10.1016/j.resinv.2020.11.004.
Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One. 2012;7(4): e35797. doi: 10.1371/journal.pone.0035797.
Downloads
Downloads
Posted
Categories
Data Availability Statement
Se han puesto a disposición del público los datos de la investigación
License
Copyright (c) 2024 Martín Inmediato (Autor/a)
This work is licensed under a Creative Commons Attribution 4.0 International License.
This preprint contains the reported license and associated copyright. Once published in an associated journal or other publisher, the published version assumes the publisher's terms and conditions.
